Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Phase I
Biotech
Equillium delivers new lupus data to Ono's doorstep
Equillium’s add-on lupus treatment improved a biomarker of kidney function in an unblinded phase 1 study, setting the ball rolling toward Ono.
Max Bayer
Apr 1, 2024 10:53am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
Surrozen stops IBD program due to dose concerns and competition
Jan 18, 2024 9:55am
Jazz halts sleep disorder med trial over 'visual disturbances'
Nov 29, 2023 10:50am
Vor Bio's dual stem cell, ADC shows consistent engraftment
Nov 9, 2023 4:10pm
Mediar gets a spark from Pfizer's Ignite program
Oct 25, 2023 10:50am